On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
On Jul. 9, 2025, pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases,…
On Jul. 9, 2025, as part of a new study, neurologists at NYU Langone Health announced they have…
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
On Jul. 2, 2025, a study jointly led by researchers at the University of California San Diego and…
On Jul. 2, 2025, researchers from the Francis Crick Institute and Liverpool John Moores University (LJMU) announces they…
On Jul. 2, 2025, researchers from the University of California, Los Angeles (UCLA) announced they have successfully grown…
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
On Jun. 30, 2025, a new study from an international team of researchers led by the Max Planck…
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
On Jun. 27, 2025, today is World Microbiome Day and the Microbiota Vault, together with all participating Local…
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
On Jun. 10, 2025, two patients treated within the past two months at the University of Washington Medical…
On Jun. 5, 2025, research from University of Southern California, Dornsife (USC Dornsife) scientists reveals how cells fix…
On Jun. 3, 2025, a study by Emory University researchers, published in Environmental Science & Technology, found that…
On Jun. 2, 2025, a first-of-its-kind international trial provides definitive evidence that people who follow a structured exercise program…
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
On May 29, 2025, Broad Institute researchers announced they have developed a technology that provides new insight into…
On May 29, 2025, The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…